Quanterix Corporation Cost-method Investments, Other than Temporary Impairment
Quanterix Corporation (QTRX) reported Cost-method Investments, Other than Temporary Impairment of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-18.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CostmethodInvestmentsOtherThanTemporaryImpairment · last filed 2019-03-18
- Quanterix Corporation cost-method investments, other than temporary impairment for fiscal 2018 was $0.00.
- Quanterix Corporation cost-method investments, other than temporary impairment for fiscal 2017 was $0.00.
- Quanterix Corporation cost-method investments, other than temporary impairment for fiscal 2016 was $0.00.
| Period end | Cost-method Investments, Other than Temporary Impairment 12 month |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-18 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-18 |
| 2016-12-31 | $0.00 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |